Tom Keith-Roach

Tom Keith-Roach, President, AstraZeneca UK

Tom is President of AstraZeneca UK, the UK’s leading biopharmaceutical company.

He joined AstraZeneca over 20 years ago and has held senior business unit, country, regional and global roles across Asia, Europe, and the US.  In his most recent role before becoming UK President, Tom led AstraZeneca's Global Respiratory & Immunology franchise across the Research & Development (R&D) and Commercial Functions.

Prior to joining AZ, Tom spent a decade in Consulting and Venture Capital, and a year as an Officer in the British Army. He holds a degree in Economics from Cambridge University.

Tom is passionate about the opportunity to make a positive difference to people’s lives through groundbreaking science and new medicines. Unleashing the potential of people and teams, and building external relationships and partnerships, to improve the health of the families and communities AZ serves is a focus for him. He is leading AZ’s efforts to put value creation at the centre of how we work with the NHS, through ambitious purpose-led partnerships and by working with constructive impatience to deliver better outcomes for patients and address inequalities at the population level.

AstraZeneca is the largest private sector investor into UK R&D, with an extensive Global manufacturing footprint. Tom also works across Government to accelerate the UK as a global centre for excellence in life sciences. He is working to bring new industry investment and jobs to the UK, to maximise the contribution our industry makes to society and the economy across all stages of the life sciences ecosystem.